SCHEMBL7126567

SCHEMBL7126567

CC(C)CC(C)C(=O)NS(C)(=O)=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 3/20 0.45
CXCR1 P25024 2/20 0.45
LARS1 Q9P2J5 1/20 0.37
MMP1 P03956 2/20 0.35
MMP2 P08253 2/20 0.35
MMP8 P22894 2/20 0.35
MMP13 P45452 2/20 0.35
MME P08473 3/20 0.33
ADAM17 P78536 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MMP9 P14780 1/20 0.33
KISS1R Q969F8 3/20 0.32
ALDH1A1 P00352 1/20 0.32
RNPEP Q9H4A4 1/20 0.32
SLC7A5 Q01650 1/20 0.32
THRB P10828 1/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24443107 0.83 LARS1 (0.37) CXCR2CXCR1LARS1MMP1MMP2
SCHEMBL15509210 0.81 LARS1 (0.36) CXCR2CXCR1LARS1MMP1MMP2
SCHEMBL15508931 0.81 LARS1 (0.36) CXCR2CXCR1LARS1MMP1MMP2
SCHEMBL27261491 0.80 CXCR2 (0.42) CXCR2CXCR1CA1CA2ALDH1A1
SCHEMBL27261487 0.80 CXCR2 (0.42) CXCR2CXCR1CA1CA2ALDH1A1
SCHEMBL12430263 0.80 CXCR2 (0.42) CXCR2CXCR1CA1CA2ALDH1A1
SCHEMBL18774972 0.79 LARS1 (0.57) CXCR2CXCR1LARS1RNPEPSLC7A5
SCHEMBL28226155 0.79 LARS1 (0.57) CXCR2CXCR1LARS1RNPEPSLC7A5
Hydrochloric Acid SCHEMBL18762524 0.78 LARS1 (0.55) CXCR2CXCR1LARS1RNPEPSLC7A5
Hydrochloric Acid SCHEMBL18762522 0.78 LARS1 (0.55) CXCR2CXCR1LARS1RNPEPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216392-A1 N - ( 2 - aryl - propionyl ) - sulfonamides and pharmaceutical preparations containing them DOMPE S.P.A. 2003-11-20 US disclosed
EP-1123276-A1 N-(2-ARYL-PROPIONYL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM Dompe' S.P.A. (IT) 2001-08-16 EP disclosed
WO-2000024710-A1 N-(2-ARYL-PROPIONYL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM DOMPE' S.P.A. (IT) 2000-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216392-A1 N - ( 2 - aryl - propionyl ) - sulfonamides and pharmaceutical preparations containing them ELANE, MPO, FPR1 CXCR2 15/4885CXCR1 133/4885LARS1 3961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.